A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.
The Nutshell
Daily News Roundup
Most Recent
This year’s prizes are awarded for advances in liver transplantation, cell biology, and leadership in biomedical science.
Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.
A pair of mechanical leg braces that are controlled by their wearer’s brain signals could help paralyzed patients walk again.
Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.
A human trial of a hepatitis C treatment is shut down after one of the participants died.
Another person has died from the rodent-borne disease after visiting Yosemite National Park.
Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.
Proposals from researchers receiving more than $1 million a year in NIH funding will be carefully picked over to avoid overlap with ongoing research.
A polar bear in a German zoo dies after contracting a virus normally found in zebras.
Subjects
- cell & molecular biology
- clinical trials
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
